Greenline Partners’s Thermo Fisher Scientific TMO Stock Holding History

Greenline Partners’s Portfolio TMO Stock Details TMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-18	Closed	-$8.96K	–	524
2025 Q1	$8.96K	Buy	+18	New	+$9.75K	﹤0.01%	213

Other funds holding TMO

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Greenline Partners's TMO Position: Q2 2025 in Review

Greenline Partners sold out of Thermo Fisher Scientific (TMO) in Q2 2025, closing a stake of 18 shares — an estimated $8.96K sold.

Greenline Partners first reported a position in TMO in Q1 2025 and held it in 1 quarter. The position peaked at $8.96K in Q1 2025. 2,454 funds tracked by Wall St. Rank hold TMO as of Q2 2025.

Greenline Partners reported no remaining Thermo Fisher Scientific position as of Q2 2025 after selling out during the quarter.
Greenline Partners sold 18 Thermo Fisher Scientific shares in Q2 2025, an estimated $8.96K.
Greenline Partners first reported a position in Thermo Fisher Scientific in Q1 2025 and held it in 1 quarter.
Greenline Partners's Thermo Fisher Scientific position peaked at $8.96K in Q1 2025.
2,454 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2025.

Based on Greenline Partners's 13F filing for Q2 2025, filed 14 Aug 2025.